AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Learn more →

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

University Health Network

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1999-01-01

Employees: 10K

Market Cap: -

Website: http://www.uhn.ca

Clinical Trials

Smoking Cessation Program in the Preadmission Clinic: The Use of a Teachable Moment

Not Applicable

Completed

Conditions: Smoking

Interventions: Drug: Champix

First Posted Date: 2010-11-18

Last Posted Date: 2017-05-08

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 300

Registration Number: NCT01243203

Locations: 🇨🇦
University Health Network, Department of Anesthesai, Toronto, Ontario, Canada

Safety and Efficacy Study of Interferon to Treat Patients Hospitalized for Influenza

Phase 1

Conditions: Influenza

Interventions: Drug: Placebo
Drug: Interferon alfacon-1

First Posted Date: 2010-10-25

Last Posted Date: 2010-10-25

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 30

Registration Number: NCT01227798

Locations: 🇨🇦
University Health Network, Toronto, Ontario, Canada

Oral Vancomycin Followed by Fecal Transplant Versus Tapering Oral Vancomycin

Phase 2

Terminated

Conditions: Laboratory Confirmed Clostridium Difficile Infection
Recurrent Clostridium Difficile Infection

Interventions: Biological: Fecal Transplant
Drug: Vancomycin

First Posted Date: 2010-10-22

Last Posted Date: 2014-12-08

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 81

Registration Number: NCT01226992

Locations: 🇨🇦
University Health Network, Toronto, Ontario, Canada

Safety and Efficacy Study of Nilotinib Combined With Mitoxantrone, Etoposide, and High-dose Cytarabine Induction Chemotherapy Followed by Consolidation for Patients With C-kit Positive Acute Myeloid Leukemia

Phase 1

Terminated

Conditions: Acute Myeloid Leukemia

Interventions: Drug: NOVE-HiDAC
Drug: Nilotinib

First Posted Date: 2010-10-18

Last Posted Date: 2015-06-22

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 12

Registration Number: NCT01222143

Locations: 🇨🇦
Princess Margaret Hospital, Toronto, Ontario, Canada

Covered Stents to Treat Hemodialysis Access Stenoses in the Cephalic Arch and Central Veins

Not Applicable

Terminated

Conditions: Renal Failure

Interventions: Procedure: PTA alone without use of the GORE VIABAHN
Device: GORE VIABAHN® Endoprosthesis with Heparin Bioactive Surface

First Posted Date: 2010-09-14

Last Posted Date: 2016-05-12

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 14

Registration Number: NCT01200914

Locations: 🇨🇦
Universtiy Health Network, Toronto, Ontario, Canada

A Study of Nilotinib in Growing Vestibular Schwannomas

Phase 2

Terminated

Conditions: Growing Vestibular Schwannomas

Interventions: Drug: Nilotinib

First Posted Date: 2010-09-14

Last Posted Date: 2017-01-11

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 2

Registration Number: NCT01201538

Locations: 🇨🇦
University Health Network, Toronto, Ontario, Canada
🇨🇦
Toronto Western Hospital, Toronto, Ontario, Canada

Postoperative Melatonin Administration and Delirium Prevention in Patients Undergoing Vascular and Cardiac Surgery

Not Applicable

Completed

Conditions: Cardiac Surgery

Interventions: Other: Melatonin

First Posted Date: 2010-09-10

Last Posted Date: 2013-02-22

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 100

Registration Number: NCT01198938

Locations: 🇨🇦
Toronto General Hospital, UHN, Toronto, Ontario, Canada

Comparing Head and Neck Endoscopy Procedures

Not Applicable

Completed

Conditions: Comparing Head And Neck Endoscopy in Healthy Patients

Interventions: Procedure: Endoscopy

First Posted Date: 2010-08-13

Last Posted Date: 2013-05-29

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 10

Registration Number: NCT01181362

Locations: 🇨🇦
University Health Network, Princess Margaret Hospital, Toronto, Ontario, Canada

Predictive Assays In Cervix Cancer

Not Applicable

Active, not recruiting

Conditions: Cervical Cancer

Interventions: Other: Tumour Biopsies and Blood Sampling

First Posted Date: 2010-08-13

Last Posted Date: 2025-02-10

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 500

Registration Number: NCT01181375

Locations: 🇨🇦
University Health Network, Princess Margaret Hospital, Toronto, Ontario, Canada

Intravenous Immunoglobulin and Plasma Exchange in Myasthenia Gravis

Phase 4

Completed

Conditions: Myasthenia Gravid

Interventions: Biological: IVIG
Procedure: PLEX

First Posted Date: 2010-08-11

Last Posted Date: 2010-08-11

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 87

Registration Number: NCT01179893

Locations: 🇨🇦
University Health Network, Toronto, Ontario, Canada

Home Terms & Conditions Privacy Policy